Logotype for Vitasora Health Limited

Vitasora Health (VHL) Status Update summary

Event summary combining transcript, slides, and related documents.

Logotype for Vitasora Health Limited

Status Update summary

26 Dec, 2025

U.S. Growth Plans and Major Deals

  • Recent capital raise completed, supporting expansion and operational changes to handle anticipated patient volume growth in the U.S. market.

  • Eight major late-stage contract negotiations underway, with potential to increase the patient pool to 350,000 Medicare patients.

  • New contracts signed with Evolent (NYSE-listed, 94,000–100,000 Medicare patients) and Physicians Alliance Corporation (5,000+ doctors, 30,000 test patients), both on value-based models.

  • Integration of Orb acquisition progressing, with $4.2 million in revenue, $2.2 million in synergy, and $1.4 million in synergies already secured, plus $1.3 million+ in upsell opportunities.

  • Focus on scaling operations and systems to support onboarding tens of thousands of new patients, especially in Medicare and chronic disease management.

Value-Based Healthcare and Connected Care Strategy

  • U.S. healthcare is shifting rapidly toward value-based contracts, with CMS aiming for all major ACOs to adopt this model by 2030.

  • Remote patient monitoring (RPM) and connected care management are central to the offering, with proven reductions in hospitalizations, ER visits, and improved pharmaceutical compliance.

  • Unique selling proposition includes the proprietary wheezo device for respiratory patients and a turnkey solution for all chronic diseases.

  • Risk-share models and fee-for-service contracts both pursued, with risk-share offering potentially lucrative returns based on shared savings.

  • RPM revenue per patient per month expected to double in 2025 due to regulatory changes and expanded reimbursement criteria.

Financial Outlook and Operational Targets

  • Achieved a run-rate ARR of US$5.5M with 40 contracted clients and a current client base of 70,000 patients; sales pipeline includes 350,000 patients.

  • Current patient programs at 6,500, targeting 30,000 within 12–18 months, with monthly revenues expected to triple in the same period.

  • Break-even on a cash flow basis anticipated before the end of the calendar year.

  • Each new contract could add $300,000–$500,000 in annual revenue per existing client through cross-selling and administrative services.

  • Risk-share contracts typically involve $8–$20 per member per month plus up to 50% of shared savings, with some contracts targeting $10–$15 million in annual savings.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more